The patients of pancreatic cystic neoplasms diagnosed and treated are increasing over the past decade.Recent and long-tern risk and benefit should be well balanced when considering treatment,follow the principle of patient-benefit.For low malignancy potential neoplasm like serous cystic tumor or branch duct intraductal papillary mucinous neoplasm,surgical indication should be reserved to those with obvious malignant potential.Decreasing perioperative mortality and morbidity should be emphasized.Comprehensive studies are needed to validate the efficacy of new diagnostic and treatment technique before applied to clinical.Oncological outcome could not be compromised in order to achieve minimal invasive effects.%我国胰腺囊性肿瘤的诊治例数逐年增加.在制定诊疗措施时,应权衡患者近远期的治疗风险和获益,秉承患者获益的原则.对恶变风险低的浆液性囊腺瘤和分支胰管型胰管内乳头状黏液性肿瘤,需严格把握手术指征,减少不必要的治疗.对于囊性肿瘤的手术,应强调降低围手术期并发症发生率和死亡率.对新的诊断和治疗技术,宜充分验证后谨慎开展,不能为了微创而牺牲肿瘤学疗效,同时要控制治疗风险.
展开▼
